1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Maryland >
  6. Cytocom Acquires ImQuest Life Sciences

M&A Deal Summary

Cytocom Acquires ImQuest Life Sciences

On July 20, 2020, Cytocom acquired life science company ImQuest Life Sciences

Acquisition Highlights
  • This is Cytocom’s 1st transaction in the Life Science sector.
  • This is Cytocom’s 1st transaction in the United States.
  • This is Cytocom’s 1st transaction in Maryland.

M&A Deal Summary
Date 2020-07-20
Target ImQuest Life Sciences
Sector Life Science
Buyer(s) Cytocom
Deal Type Add-on Acquisition

Target

ImQuest Life Sciences

Frederick, Maryland, United States
ImQuest Life Sciences, Inc. is a research and development company focused specifically on cancer, inflammation and infectious disease treatments. ImQuest Life Sciences is based in Frederick, Maryland.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Cytocom

Winter Park, Florida, United States
Category Company
Sector Life Science
DESCRIPTION

Cytocom, Inc. is a clinical-stage bio-pharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform that is designed to rebalance body's immune system. Cytocom is based in Winter Park, Florida.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Maryland M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal